Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock (NQ:CYCCP)
Historical Prices
Year:
| Date | Open | High | Low | Close | Volume | Change (%) |
|---|---|---|---|---|---|---|
| Sep 11, 2025 | 5.050 | 0 | -0.23(-4.36%) | |||
| Sep 10, 2025 | 5.220 | 5.720 | 4.980 | 5.280 | 8,320 | +0.28(+5.60%) |
| Sep 09, 2025 | 4.800 | 5.040 | 4.800 | 5.000 | 984 | +0.16(+3.31%) |
| Sep 08, 2025 | 5.040 | 5.250 | 4.800 | 4.840 | 2,941 | +0.04(+0.83%) |
| Sep 05, 2025 | 4.840 | 5.060 | 4.670 | 4.800 | 3,032 | -0.04(-0.90%) |
| Sep 04, 2025 | 4.844 | 4.844 | 4.844 | 4.844 | 245 | +0.04(+0.91%) |
| Sep 03, 2025 | 4.820 | 4.870 | 4.800 | 4.800 | 1,794 | -0.30(-5.88%) |
| Aug 29, 2025 | 5.100 | 0 | -0.19(-3.59%) | |||
| Aug 28, 2025 | 5.150 | 5.500 | 5.150 | 5.290 | 11,402 | +0.19(+3.73%) |
| Aug 27, 2025 | 4.900 | 5.650 | 4.550 | 5.100 | 11,855 | +0.35(+7.37%) |
| Aug 26, 2025 | 4.920 | 5.200 | 4.750 | 4.750 | 1,861 | -0.16(-3.26%) |
| Aug 25, 2025 | 5.350 | 5.570 | 4.850 | 4.910 | 8,785 | -0.48(-8.91%) |
| Aug 22, 2025 | 5.200 | 5.390 | 5.200 | 5.390 | 383 | -0.03(-0.55%) |
| Aug 20, 2025 | 5.420 | 34 | +0.61(+12.68%) | |||
| Aug 19, 2025 | 5.050 | 5.540 | 4.810 | 4.810 | 1,166 | -1.10(-18.61%) |
| Aug 15, 2025 | 5.910 | 188 | +0.49(+9.08%) | |||
| Aug 14, 2025 | 4.910 | 7.400 | 4.910 | 5.418 | 59,251 | -0.08(-1.49%) |
| Aug 13, 2025 | 4.070 | 6.180 | 4.070 | 5.500 | 11,103 | +1.42(+34.80%) |
| Aug 12, 2025 | 4.230 | 4.230 | 4.070 | 4.080 | 650 | -0.25(-5.77%) |
| Aug 08, 2025 | 4.330 | 14 | +0.05(+1.17%) | |||
| Aug 07, 2025 | 4.100 | 4.280 | 4.060 | 4.280 | 505 | +0.22(+5.42%) |
| Aug 06, 2025 | 4.040 | 4.360 | 4.040 | 4.060 | 801 | +0.02(+0.50%) |
| Aug 05, 2025 | 4.820 | 4.820 | 4.040 | 4.040 | 1,752 | +0.00(+0.00%) |
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.